Trial intelligence / Profile preview

Vitamin E Supplementation in Non-cyanotic Heart Disease Children with LRTI

NCT06926712Phase 4Not yet recruiting

Sponsor
Assiut University
Start
Jun 2025
Primary completion
Jun 2026
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Phase 4, randomised trial of vitamin e in lower respiratory tract infection (LRTI) (2 arms), sponsored by Assiut University. Primary endpoint: Length of Hospital Stay. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

vitamin e
03

Conditions

lower respiratory tract infection (LRTI)

Beyond the preview

Go deeper on NCT06926712.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06926712.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call